| ID | Sequence | Length | GC content |
|---|---|---|---|
| AUCCCCAUCCCGUGGAGUGGCCGGCGACAAGAUGGCAGCAGCGUGUCGG… | 936 nt | 0.5748 | |
| AUCCCGUGGAGUGGCCGGCGACAAGAUGGCAGCAGCGUGUCGGAGCGUG… | 954 nt | 0.5744 |
This gene encodes 3-hydroxyacyl-CoA dehydrogenase type II, a member of the short-chain dehydrogenase/reductase superfamily. The gene product is a mitochondrial protein that catalyzes the oxidation of a wide variety of fatty acids and steroids, and is a subunit of mitochondrial ribonuclease P, which is involved in tRNA maturation. The protein has been implicated in the development of Alzheimer disease, and mutations in the gene are the cause of 17beta-hydroxysteroid dehydrogenase type 10 (HSD10) deficiency. Several alternatively spliced transcript variants have been identified, but the full-length nature of only two transcript variants has been determined. [provided by RefSeq, Aug 2014]
A study in aged mice demonstrated that subacute thallium exposure induced sex-specific disruptions in renal energy metabolism, with protein analysis showing a downward trend for the HSD17B10 in the kidneys of aged female mice [Yao et al. DOI:10.1016/J.Fct.2025.115700].